(Q35159086)

6 August 2017

1 reference

title

New approaches in vaccine development. (English)

1 reference

6 August 2017

Claude Leclerc

1

1 reference

6 August 2017

publication date

1 October 2003

1 reference

Comparative Immunology, Microbiology & Infectious Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

26

1 reference

6 August 2017

issue

5-6

1 reference

6 August 2017

page(s)

329-341

1 reference

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

NadA, a novel vaccine candidate of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Exact prediction of a natural T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

From genome to vaccine: in silico predictions, ex vivo verification.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Antigen presentation and T cell stimulation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Exploiting dendritic cells to improve vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Antigen presentation to CD8+ T cells: cross-priming in infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Virus-like particles: a new family of delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Towards the rational design of Th1 adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Toll-like receptors in the induction of the innate immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Toll-like receptors and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Decoding the patterns of self and nonself by the innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Toll-like receptors control activation of adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Generation and maintenance of memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900018-3

7 January 2021

10.1016/S0147-9571(03)00018-3

Identifiers

DOI

1 reference

6 August 2017

1 reference